Trump election, Bitcoin hits all-time high above $93K, with a market cap $1.8T. Here's how things are different from 2021.

Large-cap stocks just saw their biggest-ever week of purchases, according to Bank of America data.

Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The first seven companies are members of the "Magnificent Seven," with Tesla being the only constituent that doesn't currently possess a trillion-dollar market cap. Meanwhile, Warren Buffett's ...

Nvidia’s stock market value briefly touched $3.53 trillion, slightly above Apple’s $3.52 trillion, LSEG data showed. Nvidia was last up 2.2 per cent, with a market value of $3.52 trillion, while Apple ...

Nvidia has tacked on more than $1 trillion in market cap in less than three months, as it looks to reclaim the title of most valuable U.S. company Nvidia Corp.'s stint as the largest U.S. company ...

Don’t invest unless prepared to lose all the money you invest. This is a high-risk investment, you shouldn’t expect to be protected if something goes wrong. With a staggering cumulative market ...

Both averages ended a six-week win streak on Friday, while a rally in mega-cap tech stocks helped fuel a seventh week of gains and a fresh record high for the Nasdaq. A big surge in bond yields ...

HDFC Small Cap Fund delivered 28.99% return since November 12, 2023. Union Small Cap Fund and Quantum Small Cap Fund delivered 25.18% and 20.08% returns respectively in the same period. After looking ...

Mega-cap growth stocks dusted their smaller peers ... Since the start of July, the Magnificent Seven stocks have trailed the rest of the market, albeit only by a few percentage points.

Data and analytics firm GlobalData has tracked the market cap and performance of the top ... with Abbott and Bristol-Myers Squibb jumping up the charts compared with last year’s first quarter.